Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diffusion Weighted MR Imaging Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: A Sub-study of the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And MoLecular Analysis)

NCT01564368 is registered in ClinicalTrials.gov with American College of Radiology Imaging Network as lead sponsor.

NCT NCT01564368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01564368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diffusion Weighted MR Imaging Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: A Sub-study of the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And MoLecular Analysis)
Lead sponsor
American College of Radiology Imaging Network
Phase
Not applicable
Overall status
Completed
Start date
August 27, 2012
Completion date
January 14, 2020
Enrollment
406 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer